483
Vimta Labs, LimitedFDA 483 - Vimta Labs, Limited - August 16, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Vimta Labs Ltd. in Hyderabad, India, revealed a significant failure to maintain adequate case histories for subjects enrolled in two bioequivalence studies. The firm did not ensure that all subjects had readable chest X-rays, a critical requirement specified in their ethics committee-approved protocols. This indicates a serious deficiency in data integrity and adherence to study protocols.
Open in Dashboard
ID · 7e6fae6b-de6a-4948-91f9-28e1d949ff0e